Phosphate Improves Mitochondrial Function and Reduces Pancreatitis in Hypertriglyceridemia
The FASEB Journal · 31.08.2025 · 39 (16)
DOI: 10.1096/fj.202501155r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 26.08.2025. Verfasst von Nidula Mullappilly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University, North Carolina, USA. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Pancreatitis, Mitochondria, Phosphates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIDDK NIH HHS, BLRD VA.
Abstract (Originalsprache)
Hypertriglyceridemia‐associated pancreatitis (HTGP) accounts for 9% to 10% of acute pancreatitis; however, the exact cause and associated factors advancing HTGP are unclear. Clinical studies have revealed that hypophosphatemia is a common factor in many patients with pancreatitis. Phosphate depletion occurs in metabolic disorders and can lead to dyslipidemia. To determine if phosphate status is critical in HTGP, we used an APOC3 transgenic mouse model of hypertriglyceridemia. We found that hypertriglyceridemic mice exhibit mild pancreatic injury with elevated intra‐acinar nonendoplasmic reticulum (non‐ER) organelle calcium levels, decreased mitochondrial function, and increased levels of pancreatic tissue myeloperoxidase and proinflammatory cytokines (TNF‐α, IL‐6, and IL‐1β) compared to mice with normal serum triglycerides. Phosphate supplementation normalized the non‐ER stored calcium levels, restored mitochondrial function, and attenuated fatty acid‐induced sustained intracellular calcium elevation in acini, protecting the pancreas from hypertriglyceridemia‐induced injury by reducing inflammation. Furthermore, phosphate supplementation reduced the severity of caerulein‐induced pancreatic injury in mice on a low‐phosphate diet under hypertriglyceridemic conditions. This study highlights an important role for phosphate in protecting the pancreas during hypertriglyceridemia by reversing the dysregulated calcium homeostasis in non‐ER organelles, restoring mitochondrial function in acini, and reducing the severity of hypertriglyceridemia‐associated pancreatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Duke University, North Carolina, USA.
- Department of Veterans Affairs Health Care System, North Carolina, USA.
ORCID-Profile: Sandip M Swain
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
- BLRD VA
- U.S. Department of Veterans Affairs (VA)
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mullappilly, N., Swain, S. M., Romac, J. M., Mikati, H., & Liddle, R. A. (2025). Phosphate Improves Mitochondrial Function and Reduces Pancreatitis in Hypertriglyceridemia. The FASEB Journal, 39(16). https://doi.org/10.1096/fj.202501155r
Vancouver
Mullappilly N, Swain SM, Romac JM, Mikati H, Liddle RA. Phosphate Improves Mitochondrial Function and Reduces Pancreatitis in Hypertriglyceridemia. The FASEB Journal. 2025;39(16). doi:10.1096/fj.202501155r
BibTeX
@article{Mullappilly2025,
author = {Mullappilly, Nidula and Swain, Sandip M and Romac, Joelle M-J and Mikati, Husam and Liddle, Rodger A},
title = {Phosphate Improves Mitochondrial Function and Reduces Pancreatitis in Hypertriglyceridemia},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {16},
doi = {10.1096/fj.202501155r}
}
EUVIMED